Literature DB >> 2049421

Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis?

E Ejlersen1, L Brandi, H Løkkegaard, J Ladefoged, R Kopp, P Haarh.   

Abstract

A randomized trial was conducted to examine the influence of initial lavage on treatment of CAPD peritonitis. Patients with hypotension and shock were excluded from the trial. Thirty-six CAPD patients with acute peritonitis were randomized to treatment with intraperitoneal antibiotics including either initial 24 hours lavage before resumption of routine CAPD schedule (prior standard approach) or continued prolonged exchanges as in routine CAPD schedule. Median time to solved infection (normalization of white cell count in dialysis effluent) was identical (3 days) in the two groups. Treatment success rate was found to be 72% in the group with initial lavage and 89% in the group with prolonged exchanges. The difference in treatment success (17%) in favour of continued CAPD schedule was not found significant (95% confidence limits--1% to 35%). The results suggest lavage to be of no clinical benefit in treatment of CAPD peritonitis in patients without profound hypotension and shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049421

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  3 in total

1.  Intravenous antibiotics with adjunctive lavage in refractory peritonitis.

Authors:  Steve Siu-Man Wong; Alex Wai-Yin Yu; Wai-Yan Lau; Ping-Kwan Chan; Yuk-Lun Cheng
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

Review 2.  Peritoneal dialysis. Prevention and control of infection.

Authors:  R Gokal
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 3.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.